新闻/Reuters/Teva’S Emrusolmin Granted U.S. FDA Fast Track Designation For Treatment Of Multiple System AtrophyTeva’S Emrusolmin Granted U.S. FDA Fast Track Designation For Treatment Of Multiple System AtrophyRefinitiv阅读少于1分钟TEVATeva Pharmaceutical Industries Ltd TEVA:TEVA’S EMRUSOLMIN GRANTED U.S. FDA FAST TRACK DESIGNATION FOR TREATMENT OF MULTIPLE SYSTEM ATROPHYReuters以色列股票美国股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html显示更多登录或创建永久免费帐户以阅读此新闻我们开始吧
